A home hospital for progressive tumor diseases - Costs and benefit;Homehospital für Krebskranke im fortgeschrittenen Stadium: Kosten und Nutzen

Zeitschrift fur Arztliche Fortbildung und Qualitatssicherung

Volumn 91, Issue 2, 1997, Pages 117-123

  Tanneberger, Stephan ^a,c   Pannuti, Franco ^b   Mirri, Rossana ^a   Panetta, Achille ^b   Mariano, Paolo ^a   Giordani, Stefano ^a   Strocchni, Elena ^a   Farabegoli, Gildino ^a  

^a Associazione Nazionale Tumori   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c NONE   (Germany)

Author keywords

Bologna; Homehospital; Quality of life; Tumor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HEALTH CARE QUALITY; HOSPICE; HUMAN; ITALY; MALE; MIDDLE AGED; NEOPLASM; PALLIATIVE THERAPY; PATHOLOGY; PATIENT CARE; QUALITY OF LIFE; TERMINAL CARE;

ADULT; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; FEMALE; HOSPICES; HUMANS; ITALY; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PALLIATIVE CARE; PATIENT CARE TEAM; QUALITY ASSURANCE, HEALTH CARE; QUALITY OF LIFE; TERMINAL CARE;

EID: 0031086232     PISSN: 14317621     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bachelard B (1990) Vergleich der Kosten zuhause und in Einrichtungen. In: Eschmann P, Kocher G, Spescha E (ed) Ambulante Krankenpflege. Bern: Hans Huber
2. Beck-friejs B, Norberg H, Strang P (1991) Cost analysis and ethical aspects of hospital-based home care for terminal cancer patients. Scand. J. Prim. Health Care 9: 259-264.
3. Berenson R, Holohan J (1992) Sources of the growth in Medicare physician expenditures. JAMA 26 : 687-691
4. Calman KC, Mc Vie JG, Soukop M, Richardson M, Donald J (1978) Cost of outpatient chemotherapy. Brit Med J: 493-494
5. Cang SA, Clark F (1978) Home care of the sick- an emerging general analysis based on schemes in France Commun. Health. 9: 167-172
6. Conkling V (1989) Continuity of Care Issues for Cancer patients and Families. Cancer 64, Suppl 1: 290-294
7. Doll R, Fraument Jr JF. Muir CS (1994) Trends in Cancer Incidence and Mortality. Cold Spring Harbor Laboratory Press
8. Ferris FD, Wodinski HB, Kerr IG, Sone M, Hume S, Coons C (1991) A cost-minimization study of cancer patients requiring a narcotic infusion in hospital and at home. J Clin Epidemiol 44: 313-327
9. Findley M (1995) Cost analysis of palliative chemotherapy for patients with gastrointestinal malignancy. Ann Oncol 6: 205-207
10. Friedlander ML, Tauersal MHN (1982) Counting the Cost of Cancer Therapy. Eur. J. Cancer 18: 1237-1241
11. Giordani S, Farabegoli G, Sapio A, Scaglioso F, de Pasquale A, Behfar A, Ognibene G, Martoni A, Piana E, Pannuti F (1995) Ospedale Domiciliari Oncologici-ANT (ODO-ANT). Gli Ospedali della Vita 22:113-120.
12. Glimelius B, Hoffman K, Graf W, Haglund U, Nyren O, Pahlman L. Sjoden PO (1995) Cost-effectivness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol 6: 267-274
13. Goodwin PJ, Feld R, Warde P, Ginsberg RJ (1990) The costs of cancer therapy. Eur. J. Cancer 26: 223-225
14. Hill LT (1994) Cost-effectiveness of Home/Hospice Palliative and Supportive Care. J Natl Cancer Inst 86: 63-64
15. Hoel DG, Davis DL, Miller AB (1992) Trends in cancer mortality in 15 industrialized countries, 1969-1986. J Natl Cancer Inst. 84: 313-320
16. Lyn H, Ament M, Fleming CR, Shike M, Steiger E (1995) Current use and clinical outcme of home parenteral and enteral nutrition therapies in the United States. Gastroenterology 109: 355-365
17. Kleeberg U (1993) Voraussetzungen für eine häusliche Pflege. Dt Ärztebl 90: A2- 2905-2906
18. Knowelden J, Westlake L, Wright K, Clark SJ (1991) Peterborough Hospital at Home: an evaluation. J Publ Health Med 13: 182-188
19. Luce BR, Elixhauser A (1990) Estimating costs in the economic evaluation of medical technologies. Int J Health Techn Ass Health Care 6: 57-75
20. Mor V, Allen SM, Siegel C, Houts P (1992) Determinants of need and unmet need among cancer patients residing at home. HSR: Health Serv Res 27: 337-360
21. Mowat IG, Morgan RT (1982) Peterborough Hospital at Home Scheme. Brit Med J 284: 641-643
22. Pannuti F (1988) Home Care for advanced and very advanced cancer patients: The Bologna experience. J Pall Care 4: 54-57
23. Pannuti F (1989) Pensieri in liberta 199+1. Bologna: Aulo Gaggi Editore
24. Pannuti F (1992) Parliamo insieme. Bologna. Aulo Gaggi Editore
25. Pannuti F. Tanneberger St (1992) The Bologna Eubiosia Project: Hospital at Home Care for Advanced Cancer Patients J Pall Care 8: 11-17
26. Pannuti F, Tanneberger St (1993) Dying with dignity: Illusion, hope or human right? World Health Forum 14: 172-173
27. Pannuti F, Tanneberger St. Lelli G, Piana E (1992) Is Ondansetron too expensive? Lancet 339: 614
28. Rees GJG (1985) Cost-effectiveness in Oncology, Lancet: 1405-1407.
29. Smith TJ, Hillner BE, Desch CE (1993) Efficacy and Cost-Effectiveness of Cancer Treatment: Rational Alloction of Rersources based on decison Analysis. J Natl Cancer Inst 85: 1460-1474
30. Souadjian JV, Bhaskar B , Briscoe KE, Opfell RW, Agopian JM (1992) Home chemotherapy: Safety and Cost effectiveness. Proc Ann Meet Amer Soc Clin Oncol 11 A: 1436
31. Sorochan M, Beattie BL (1994) Doe home care save money ? World Health 47: 18-19
32. Steel K, Tjassing H (1994) Health care moves to the home. World Health 47: 16-17
33. Stein R (1996) Nützt es dem Krebskranken? Berliner Ärzte 33: 28-30
34. Stoddard S (1987) Die Hospiz-Bewegung. Freiburg im Breisgau: Lambertus
35. Tanneberger St. Pannuti F, Houts P, Bucher J (1995) Jemand in meiner Familie hat Krebs: Was kann ich tun? München: Zuckschwerdt
36. Tanneberger St (1995) Euthanasie: Ablehnung verpflichtet zu Alternativen. Versicherungsmedizin 47: 42-46.
37. Tanneberger St, Guaraldi M, Pannuti F (1996) Das Problem Bronchuskarzinom: Epikritische Betrachtung, Schriftenreihe des Arbeitskreises Bronchuskarzinom der Österreichischen Gesellschaft für Lungenerkrankungen 15: 31-49
38. Tanneberger St, Pannuti F (1996) Can home care be an option in overcoming the lack of hospital beds in developing countries? World Health Forum (in press)
39. Udvarhelyi S, Colditz GA, Rai A, Epstein AM (1992) Cost-effectiveness and cost-benefit analysis in the medical literature. Ann Int Med 116: 238-244
40. Verband der privaten Krankenversicherung e.V., Köln (1993) Dt Ärzteblatt 90: A2-491
41. World Health Organization (1987) Palliative Cancer Care. Copenhagen, WHO Regional Office for Europe.